
Arbutus Biopharma Corporation ABUS
$ 4.29
-3.05%
Annual report 2025
added 03-23-2026
Arbutus Biopharma Corporation DPO Ratio 2011-2026 | ABUS
Annual DPO Ratio Arbutus Biopharma Corporation
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | - | - | 23 | 15.2 | 20.1 | 11.6 | 19.2 | 18.5 | 19.3 | 20.7 | 16.2 | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 23 | 11.6 | 18.2 |
DPO Ratio of other stocks in the Biotechnology industry
| Issuer | DPO Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Incyte Corporation
INCY
|
200 | $ 90.47 | 0.02 % | $ 17.7 B | ||
|
Aeterna Zentaris
AEZS
|
34.4 K | - | 5.93 % | $ 314 M | ||
|
Albireo Pharma
ALBO
|
1.59 K | - | -0.23 % | $ 916 M | ||
|
I-Mab
IMAB
|
2.24 K | - | - | $ 866 M | ||
|
Alexion Pharmaceuticals, Inc.
ALXN
|
78.2 | - | - | $ 40.3 B | ||
|
Midatech Pharma plc
MTP
|
162 | - | -18.52 % | $ 27.3 M | ||
|
Amphastar Pharmaceuticals
AMPH
|
31.7 | $ 19.43 | 1.04 % | $ 908 M | ||
|
AgeX Therapeutics
AGE
|
9.04 K | - | -10.17 % | $ 12.2 K | ||
|
Acorda Therapeutics
ACOR
|
277 | - | -24.86 % | $ 820 K | ||
|
Acasti Pharma
ACST
|
4.39 K | - | 4.01 % | $ 150 M | ||
|
Институт стволовых клеток человека
ISKJ
|
115 | - | - | - | ||
|
CollPlant Biotechnologies Ltd.
CLGN
|
72.6 | $ 0.72 | 18.96 % | $ 8.25 M | ||
|
Advaxis
ADXS
|
143 K | - | -9.65 % | $ 45.9 M | ||
|
Exelixis
EXEL
|
148 | $ 41.39 | -0.05 % | $ 11.2 B | ||
|
Ayala Pharmaceuticals
AYLA
|
2.21 K | - | - | $ 7.46 M | ||
|
Aytu BioScience
AYTU
|
186 | $ 2.59 | -1.52 % | $ 16.3 M | ||
|
BioDelivery Sciences International
BDSI
|
96.3 | - | -4.8 % | $ 255 M | ||
|
BeiGene, Ltd.
BGNE
|
915 | - | 0.49 % | $ 251 B | ||
|
AIkido Pharma
AIKI
|
32.8 K | - | 1.93 % | $ 17.4 M | ||
|
Ionis Pharmaceuticals
IONS
|
815 | $ 69.54 | -1.77 % | $ 11.1 B | ||
|
Brickell Biotech
BBI
|
105 | - | -5.38 % | $ 6.06 M | ||
|
Harmony Biosciences Holdings
HRMY
|
28.9 | $ 27.01 | -2.14 % | $ 1.55 B | ||
|
Ampio Pharmaceuticals
AMPE
|
2.85 K | - | -11.43 % | $ 502 K |